Previous studies have shown 5′ cap-mediated translation of proteins is up-regulated in many or most cancers, including mesothelioma, and that downregulation of the eIF4F complex activity in mesothelioma is associated with loss of the malignant phenotype and increased sensitivity to cytotoxic therapies [9, 10]. This evidence concerns the gene EIF4G1 and mesothelioma.